Mergers and Acquisitions Assessed in the First Quarter of 2019
The Competition and Tariff Commission assessed and approved the following mergers and acquisitions: –
Transaction Details
i) Acquisition of Lancet Laboratories Zimbabwe (Pty) Limited by Cerba Healthcare Africa
The transaction involved the acquisition of 70% of the issued share capital of Lancet Laboratories Zimbabwe (Pty) Limited by Cerba Healthcare Africa. Cerba Healthcare Africa is a joint venture company which was incorporated in 2018 by Cerba Healthcare International and Lancet Services Company (Pty) Limited. Cerba Healthcare Africa was incorporated jointly with Cerba Healthcare International and Lancet South Africa for the purposes of developing a leading network routine laboratories in Africa.
Lancet Laboratories Services Company (Pty) Limited is South African registered company with various subsidiaries in West, East African and Southern African Region where it operates a network of clinical laboratories in these regions.
The transaction was classified as a horizontal merger.
Determination
The transaction was approved without conditions.
Transaction Details
ii) Acquisition of 100% stake in Delta Gold Zimbabwe (Private) Limited by Dallagio Investments (Private) Limited
The transaction involved the acquisition of 100% share in Delta Gold Zimbabwe (Private) Limited by Dallagio Investments (Private) Limited. Dallagio Investments (Private) Limited – the acquiring company is an investment holding company incorporated in Zimbabwe whose aim is to invest in mining industry.
Delta Gold Zimbabwe (Private) Limited, which owns Eureka Gold Mining Project, has not been able to establish a full-scale mining operations from 1999 to 2011 due to financial constraints. Both parties are in the mining sector.
The transaction was classified as a horizontal merger.
Determination
The transaction was approved without conditions.
The Commission would like to thank its stakeholders for their co-operation during consultations.
